undefined undefined
NaN.000
NaN.00%
Nuvectis Pharma press release (NASDAQ:NVCT): Q1 EPS of -$0.25. Cash, and cash equivalents were $19.5 million as of March 31, 2024, compared to $19.1 million as of December 31, 2023. More on Nuvectis ...
05-07 22:35
Highly Synergistic Antiproliferative Activity in EGFR-resistant Cells in Combination with Osimertinib, the Active Ingredient in TagrissoTMSingle Agent Antiproliferative Activity in Cells Resistant to Alectinib, the
04-08 20:41
Nuvectis Pharma (NASDAQ:NVCT) reported its Q3 earnings results on Wednesday, No...
2023-11-08 21:10
What is the target price for Nuvectis Pharma (NVCT)? The latest price target...
2023-09-15 18:10
Nuvectis Pharma, Inc. (NASDAQ:NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of
2023-09-12 20:02
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a new focus of traders looking for the next huge move. High short interest and steep borrowing costs are among the common traits that could lead to a short squeeze.
2023-08-14 22:49
Nuvectis Pharma (NASDAQ:NVCT) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.29) by 31.03 percent. This is a 35.71 percent decrease over losses of $(0.28) per share from
2023-08-09 20:33
8月1日报道,根据美国证券交易委员会(SEC)8月1日披露的文件,$Nuvectis Pharma(NVCT.US)$股东Mosseri Marlio Cha...
2023-08-01 08:39
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
2023-07-13 19:39
Nuvectis Pharma Set To Join Russell 2000 And Russell 3000 Indexes
2023-06-20 20:05